Market closed
10x Genomics/$TXG
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About 10x Genomics
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Ticker
$TXG
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
1,259
Website
10x Genomics Metrics
BasicAdvanced
$1.6B
Market cap
-
P/E ratio
-$1.53
EPS
1.85
Beta
-
Dividend rate
Price and volume
Market cap
$1.6B
Beta
1.85
52-week high
$57.90
52-week low
$12.95
Average daily volume
2M
Financial strength
Current ratio
4.899
Quick ratio
3.973
Long term debt to equity
10.578
Total debt to equity
11.881
Interest coverage (TTM)
-14,069.17%
Management effectiveness
Return on assets (TTM)
-11.19%
Return on equity (TTM)
-24.87%
Valuation
Price to revenue (TTM)
2.587
Price to book
2.28
Price to tangible book (TTM)
2.35
Price to free cash flow (TTM)
65.051
Growth
Revenue change (TTM)
6.56%
Earnings per share change (TTM)
-20.65%
3-year revenue growth (CAGR)
11.10%
3-year earnings per share growth (CAGR)
-28.50%
What the Analysts think about 10x Genomics
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for 10x Genomics stock.
10x Genomics Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
10x Genomics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
10x Genomics News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for 10x Genomics stock?
10x Genomics (TXG) has a market cap of $1.6B as of December 21, 2024.
What is the P/E ratio for 10x Genomics stock?
The price to earnings (P/E) ratio for 10x Genomics (TXG) stock is 0 as of December 21, 2024.
Does 10x Genomics stock pay dividends?
No, 10x Genomics (TXG) stock does not pay dividends to its shareholders as of December 21, 2024.
When is the next 10x Genomics dividend payment date?
10x Genomics (TXG) stock does not pay dividends to its shareholders.
What is the beta indicator for 10x Genomics?
10x Genomics (TXG) has a beta rating of 1.85. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.